Join to View Full Profile
5 E 98th St1st FloorNew York, NY 10029
Phone+1 212-241-6854
Fax+1 212-241-4460
Dr. Lublin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1975 - 1976
Zucker School of Medicine at Hofstra/NorthwellResidency, Neurology, 1974 - 1975- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1973 - 1974
Jacobi Medical Center/Albert Einstein College of MedicineInternship, Internal Medicine, 1972 - 1973
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1972
Certifications & Licensure
NJ State Medical License 2020 - 2027
NY State Medical License 1973 - 2027
PA State Medical License 1976 - 2026
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2003-2018
- America's Top Doctors Castle Connolly, 2002-2018
- New York Magazine: Top Doctors Castle Connolly, 2002-2008, 2015
- Join now to see all
Clinical Trials
- Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx Start of enrollment: 2005 Jan 01
- Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis Start of enrollment: 2002 Dec 01
- Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks Start of enrollment: 2003 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Ponesimod as add-on treatment in patients with active relapsing multiple sclerosis under dimethyl fumarate (POINT): A phase 3, randomized, placebo-controlled clinical ...Ludwig Kappos, Michel Burcklen, Daniele D'Ambrosio, Robert J Fox, Mark S Freedman
Multiple Sclerosis and Related Disorders. 2025-10-01 - AI-driven reclassification of multiple sclerosis progression.Habib Ganjgahi, Dieter A Häring, Piet Aarden, Gordon Graham, Yang Sun
Nature Medicine. 2025-08-20 - Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis.Ali Manouchehrinia, Kathryn C Fitzgerald, Amber Salter, Ruth Ann Marrie, Lars Alfredsson
Annals of Neurology. 2025-08-07
Press Mentions
2025 Best Practices Update Released for Managing MS in a Changing LandscapeApril 16th, 2025- Two Mount Sinai Experts Receive Honors from the National Multiple Sclerosis SocietySeptember 16th, 2021
- MS Treatment Baby-Boom: Quadruplets!May 6th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
